NCT00099242

Data

{
  "briefSummary": "The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.",
  "completionDate": "2006-01",
  "conditions": [
    "Alzheimer's Disease",
    "Dementia, Alzheimer Type"
  ],
  "enrollmentCount": 1040,
  "enrollmentType": null,
  "nctId": "NCT00099242",
  "phase": "PHASE3",
  "sponsorId": "novartis-pharmaceuticals",
  "startDate": "2003-11",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00099242"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version